169 related articles for article (PubMed ID: 37294384)
1. Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study.
Xu M; Hao Y; Zhou H; Shi Z; Si J; Song Z
Med Oncol; 2023 Jun; 40(7):198. PubMed ID: 37294384
[TBL] [Abstract][Full Text] [Related]
2. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation.
Kadota K; Yeh YC; D'Angelo SP; Moreira AL; Kuk D; Sima CS; Riely GJ; Arcila ME; Kris MG; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Aug; 38(8):1118-27. PubMed ID: 25029118
[TBL] [Abstract][Full Text] [Related]
3. Clinical course of stage IV invasive mucinous adenocarcinoma of the lung.
Cha YJ; Kim HR; Lee HJ; Cho BC; Shim HS
Lung Cancer; 2016 Dec; 102():82-88. PubMed ID: 27987593
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung.
Ueda D; Ito M; Tsutani Y; Giménez-Capitán A; Román-Lladó R; Pérez-Rosado A; Aguado C; Kushitani K; Miyata Y; Arihiro K; Molina-Vila MA; Rosell R; Takeshima Y; Okada M
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3709-3718. PubMed ID: 33796913
[TBL] [Abstract][Full Text] [Related]
5. Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers.
Duruisseaux M; Antoine M; Rabbe N; Rodenas A; Mc Leer-Florin A; Lacave R; Poulot V; Duchêne B; Van Seuningen I; Cadranel J; Wislez M
Lung Cancer; 2017 Jul; 109():92-100. PubMed ID: 28577958
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.
Woo W; Yang YH; Cha YJ; Moon DH; Shim HS; Cho A; Kim BJ; Kim HE; Park BJ; Lee JG; Kim DJ; Paik HC; Lee S; Lee CY
Thorac Cancer; 2022 Dec; 13(23):3310-3321. PubMed ID: 36345148
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma.
Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
J Cancer Res Clin Oncol; 2016 Aug; 142(8):1837-45. PubMed ID: 27342421
[TBL] [Abstract][Full Text] [Related]
8. A case of invasive mucinous adenocarcinoma of the lung showing stepwise progression at the primary site.
Kawai H; Sugano M; Nakano N; Muratani M; Sakashita S; Goto Y; Noguchi M
Lung Cancer; 2019 Oct; 136():94-97. PubMed ID: 31472337
[TBL] [Abstract][Full Text] [Related]
9. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma.
Matsui T; Sakakura N; Koyama S; Nakanishi K; Sasaki E; Kato S; Hosoda W; Murakami Y; Kuroda H; Yatabe Y
Ann Thorac Surg; 2021 Oct; 112(4):1118-1126. PubMed ID: 33242433
[TBL] [Abstract][Full Text] [Related]
11. Radiological and clinical features of large consolidative-type pulmonary invasive mucinous adenocarcinoma.
Chen J; Qi L; Wang J; Xue L; Xue Q; Jia J; Zhang G; Liu J; Li F; Cui S
Clin Respir J; 2024 Mar; 18(3):e13743. PubMed ID: 38529681
[TBL] [Abstract][Full Text] [Related]
12. ALK-rearranged adenocarcinoma with extensive mucin production can mimic mucinous adenocarcinoma: clinicopathological analysis and comprehensive histological comparison with KRAS-mutated mucinous adenocarcinoma.
Cha YJ; Han J; Hwang SH; Lee TB; Kim H; Zo JI
Pathology; 2016 Jun; 48(4):325-9. PubMed ID: 27114375
[TBL] [Abstract][Full Text] [Related]
13. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
[TBL] [Abstract][Full Text] [Related]
14. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
[TBL] [Abstract][Full Text] [Related]
15. Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with
Drilon A; Schoenfeld AJ; Arbour KC; Litvak A; Ni A; Montecalvo J; Yu HA; Panora E; Ahn L; Kennedy M; Haughney-Siller A; Miller V; Ginsberg M; Ladanyi M; Arcila M; Rekhtman N; Kris MG; Riely GJ
Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30936194
[No Abstract] [Full Text] [Related]
16. Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis.
Boland JM; Maleszewski JJ; Wampfler JA; Voss JS; Kipp BR; Yang P; Yi ES
Hum Pathol; 2018 Jan; 71():8-19. PubMed ID: 28823574
[TBL] [Abstract][Full Text] [Related]
17. Anaplastic lymphoma kinase fusion protein expression is associated with a favorable prognosis in resected invasive mucinous lung adenocarcinoma: A retrospective study from two Chinese tertiary hospitals.
Wang J; Wei P; Liu J; Su P; Xing A; Jing H; Hao J
J Cancer Res Ther; 2022 Apr; 18(2):445-451. PubMed ID: 35645113
[TBL] [Abstract][Full Text] [Related]
18. Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma.
Cai L; Wang J; Yan J; Zeng J; Zhu L; Liang J; Pan C; Huang X; Jin J; Xu Y; Wang F; Shao Y; Xu Q; Xia G; Xing M; Xu X; Jiang Y
Front Oncol; 2020; 10():603671. PubMed ID: 33505917
[TBL] [Abstract][Full Text] [Related]
19. SMARCA4 mutations in KRAS-mutant lung adenocarcinoma: a multi-cohort analysis.
Liu L; Ahmed T; Petty WJ; Grant S; Ruiz J; Lycan TW; Topaloglu U; Chou PC; Miller LD; Hawkins GA; Alexander-Miller MA; O'Neill SS; Powell BL; D'Agostino RB; Munden RF; Pasche B; Zhang W
Mol Oncol; 2021 Feb; 15(2):462-472. PubMed ID: 33107184
[TBL] [Abstract][Full Text] [Related]
20. Invasive mucinous adenocarcinoma of the lung: clinicopathological features,
Sun X; Zeng B; Tan X; Chen Z; Pan X; Jiang L
Ann Nucl Med; 2023 Mar; 37(3):198-207. PubMed ID: 36538165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
